163 related articles for article (PubMed ID: 38755600)
1. Therapeutic potentials of FexMoyS-PEG nanoparticles in colorectal cancer: a multimodal approach via ROS-ferroptosis-glycolysis regulation.
Yu Z; Wang C; Ye Y; Wang S; Jiang K
J Nanobiotechnology; 2024 May; 22(1):253. PubMed ID: 38755600
[TBL] [Abstract][Full Text] [Related]
2. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
[No Abstract] [Full Text] [Related]
3. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic Iron Oxide-Erastin-Polyethylene Glycol Nanotherapeutic Platform: A Ferroptosis-Based Approach for the Integrated Diagnosis and Treatment of Nasopharyngeal Cancer.
Tang H; Zhou X; Liu L; Wang Z; Wang C; Luo N; Jin G
Mol Pharm; 2024 Jun; 21(6):2767-2780. PubMed ID: 38736196
[TBL] [Abstract][Full Text] [Related]
5. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
6. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
7. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy.
Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J
J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950
[TBL] [Abstract][Full Text] [Related]
8. Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis.
Zhu L; Dai Y; Gao L; Zhao Q
Int J Nanomedicine; 2021; 16():4559-4577. PubMed ID: 34267513
[TBL] [Abstract][Full Text] [Related]
9. Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect.
Dong Y; Dong S; Wang Z; Feng L; Sun Q; Chen G; He F; Liu S; Li W; Yang P
ACS Appl Mater Interfaces; 2020 Nov; 12(47):52479-52491. PubMed ID: 33196186
[TBL] [Abstract][Full Text] [Related]
10. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
11. PEGylated chitosan-coated nanophotosensitizers for effective cancer treatment by photothermal-photodynamic therapy combined with glutathione depletion.
Chen YH; Liu IJ; Lin TC; Tsai MC; Hu SH; Hsu TC; Wu YT; Tzang BS; Chiang WH
Int J Biol Macromol; 2024 May; 266(Pt 2):131359. PubMed ID: 38580018
[TBL] [Abstract][Full Text] [Related]
12. Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation.
Shen LD; Qi WH; Bai JJ; Zuo CY; Bai DL; Gao WD; Zong XL; Hao TT; Ma Y; Cao GC
Anat Rec (Hoboken); 2021 Feb; 304(2):313-322. PubMed ID: 31961485
[TBL] [Abstract][Full Text] [Related]
13. A tumor microenvironment responsive nanosystem for chemodynamic/chemical synergistic theranostics of colorectal cancer.
Wang L; Xia J; Fan H; Hou M; Wang H; Wang X; Zhang K; Cao L; Liu X; Ling J; Yu H; Wu X; Sun J
Theranostics; 2021; 11(18):8909-8925. PubMed ID: 34522218
[No Abstract] [Full Text] [Related]
14. Auriculasin enhances ROS generation to regulate colorectal cancer cell apoptosis, ferroptosis, oxeiptosis, invasion and colony formation.
Wang CX; Chen LH; Zhuang HB; Shi ZS; Chen ZC; Pan JP; Hong ZS
Biochem Biophys Res Commun; 2022 Jan; 587():99-106. PubMed ID: 34872005
[TBL] [Abstract][Full Text] [Related]
15. Engineered nanomedicine for myeloma and bone microenvironment targeting.
Swami A; Reagan MR; Basto P; Mishima Y; Kamaly N; Glavey S; Zhang S; Moschetta M; Seevaratnam D; Zhang Y; Liu J; Memarzadeh M; Wu J; Manier S; Shi J; Bertrand N; Lu ZN; Nagano K; Baron R; Sacco A; Roccaro AM; Farokhzad OC; Ghobrial IM
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10287-92. PubMed ID: 24982170
[TBL] [Abstract][Full Text] [Related]
16. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
17. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells.
Wei R; Zhao Y; Wang J; Yang X; Li S; Wang Y; Yang X; Fei J; Hao X; Zhao Y; Gui L; Ding X
Int J Biol Sci; 2021; 17(11):2703-2717. PubMed ID: 34345202
[No Abstract] [Full Text] [Related]
18. Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem.
Ren J; Zhou J; Liu H; Jiao X; Cao Y; Xu Z; Kang Y; Xue P
Theranostics; 2021; 11(19):9470-9491. PubMed ID: 34646381
[No Abstract] [Full Text] [Related]
19. Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer.
Li X; Zou Q; Zhang J; Zhang P; Zhou X; Yalamarty SSK; Liang X; Liu Y; Zheng Q; Gao J
Int J Nanomedicine; 2020; 15():6791-6811. PubMed ID: 32982234
[TBL] [Abstract][Full Text] [Related]
20. Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer.
Li X; Niu J; Deng L; Yu Y; Zhang L; Chen Q; Zhao J; Wang B; Gao H
Acta Biomater; 2024 Jan; 173():432-441. PubMed ID: 37984629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]